X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Immunity

期刊標題檢索 IMMUNITY 最新評論: How long does the first external audit usually take? (2022-04-06)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Immunity]您好,您是該頁面的第 107933 位訪客。

期刊簡介
期刊名稱Immunity Immunity
LetPub Score
9.8
50 ratings
Rate

Reputation
10.0

Influence
9.8

Speed
9.1

期刊簡稱IMMUNITY
ISSN1074-7613
E-ISSN1097-4180
h-index355
CiteScore
CiteScoreSJRSNIPCiteScore Rank
49.4013.5783.929
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Infectious Diseases
Q14 / 344
Category: Medicine
Subcategory: Immunology
Q13 / 236
Category: Medicine
Subcategory: Immunology and Allergy
Q13 / 233

自引率 (2023-2024)2.00%自引率趨勢
掲載範囲
Immunity is a monthly journal which publishes research articles and reviews of general interest in the entire discipline of immunology. Immunity was founded in the belief that advances in molecular and cellular immunology have brought immunology to a point at which a journal of high quality should be able to provide a unifying intellectual view, but the mandate for Immunity is not restricted to any particular level of analysis or to any particular type of system. The title Immunity is meant to indicate a breadth of interest extending beyond the formal definition of immunology, and into all systems that contribute to, or interact with, the immune system of the organism.
官方網站http://www.cell.com/immunity/home
在線稿件提交https://www.editorialmanager.com/IMMUNITY
開放訪問No
出版商Cell Press
主題領域医学
出版國/地區UNITED STATES
發行頻率月刊
創刊年0
每年文章數165每年文章數趨勢
黃金OA百分比73.29%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ14/181
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1074-7613%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 6 Month(s)
競爭力 *來自作者的數據: About 50%
參考鏈接
相關期刊 【Immunity】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    NATURE IMMUNOLOGYH-index: 344

    CiteScore: 40.00
    Annual Review of ImmunologyH-index: 279

    CiteScore: 57.20
    Cellular & Molecular ImmunologyH-index: 64

    CiteScore: 31.20
    TRENDS IN IMMUNOLOGYH-index: 209

    CiteScore: 25.10
    JOURNAL OF EXPERIMENTAL MEDICINEH-index: 411

    CiteScore: 26.60
    AUTOIMMUNITY REVIEWSH-index: 103

    CiteScore: 24.70
    BRAIN BEHAVIOR AND IMMUNITYH-index: 127

    CiteScore: 29.60
    JOURNAL OF AUTOIMMUNITYH-index: 101

    CiteScore: 27.90
    Mucosal ImmunologyH-index: 82

    CiteScore: 16.60
    學科內最受檢索的期刊 頁面查看次數
    International Immunopharmacology316287
    JOURNAL OF IMMUNOLOGY156690
    Cellular & Molecular Immunology107432
    Vaccine104772
    JOURNAL OF EXPERIMENTAL MEDICINE99452
    MICROBIAL PATHOGENESIS94241
    MOLECULAR IMMUNOLOGY91040
    INFLAMMATION89741
    BRAIN BEHAVIOR AND IMMUNITY84724
    IMMUNOLOGY78553
  •  

    Immunity Immunity
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Immunity] 的評論撰寫評論
作者: 重阳睿文


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-04-06 20:48:07 評論於
How long does the first external audit usually take?
(0) 讚! | 重阳睿文

作者: 本尼迪克特梦露


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2022-01-07 08:10:04 評論於
Review speed: 2.0 | Submission hit rate: 5.0 Research focus: tumors; infections; basic immunology experience sharing: Immunology research journals are roughly as follows: Tier 1 - Cell, Nature, Science Tier 2 - Cell sub-journal Immunity, which has been rapidly rising in recent years, with an impact factor surpassing Nature Immunology; Nature sub-journal Nature Immunology, which has seen a slight decrease in impact factor in recent years, but remains one of the best journals in the field of immunology; Nature sub-journal Nature Medicine, one of the best choices if there is a clear mechanistic study with potential clinical applications. In any case, the boss's submission preference is to submit to Immunity > Nature Immunology > Science Immunology, excluding CNS. Tier 3 - Journal of Experimental Medicine, a longstanding immunology journal, whose impact factor has been gradually declining, but the articles published therein are not to be taken lightly. However, in the past two years, they have also been accepting more research from other medical fields; Nature sub-journal Nature Cell Biology, which leans more towards classical cell biology, but occasionally features articles with an immunological focus; Journal of Clinical Investigation, a longstanding medical research journal, and Science's newer sub-journal Science Translational Medicine are also in this tier. Additionally, journals like Journal of Allergy and Clinical Immunology, Blood, and Gastroenterology are also very reputable
(0) 讚! | 本尼迪克特梦露

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:53:29 評論於
SPSS (Statistical Product and Service Solutions), "Statistical Product and Service Solutions"
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 20:41:39 評論於
Mainly write about the use of animals, cell culture methods; main experimental operation methods; operation methods of techniques and instruments
(0) 讚! | 维尔娜菲茨杰拉德

作者: 八坂篷蔚


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 22:32:11 評論於
What is required in the general method?
(0) 讚! | 八坂篷蔚

作者: 上清雨真


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 09:44:37 評論於
What statistical method is generally used?
(0) 讚! | 上清雨真

作者: 日月小菊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2020-06-29 09:16:52 評論於
22.5, exceeded NI
(0) 讚! | 日月小菊

作者: 阿尔杰伯莎


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-05-18 22:16:45 評論於
Cell subjournal. Immunology experts. It's hard. But it feels like some groups have managed to publish a lot after getting the hang of it
(0) 讚! | 阿尔杰伯莎

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 15:20:13 評論於
Who can predict how many points there will be next year?
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2013-12-26 22:07:38 評論於
Review Speed: 2.0 | Submission Hit Rate: 5.0
Sharing experience: The journal Immunity is more objective than the three major journals C N S, and values your work itself more. As long as your work is innovative enough and the data is relatively systematic, they will choose to send your article for review. The latter three journals value the weight of the author, and it is difficult to have a review opportunity if you do not have a heavyweight big name attached. My article took a month and a half for the first review in this journal (on the 32nd day, all reviewer comments returned to the editor, they will consider for 11 days, so the comments returned to me one and a half months later). After revising and resubmitting, the second review only waited for 14 days, all comments returned to the editor, and after 11 days of discussion, the comments were returned to me
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-10-31 23:17:58 評論於
Review speed: 6.0 | Submission success rate: 50.0 Experience sharing: If my problem was a Death Star, this article is a photon torpedo
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2011-08-09 08:44:17 評論於
very difficult
(0) 讚! | 凌霄高洁

作者: 凌霄高洁


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2010-08-08 09:58:59 評論於
Difficult!
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Immunity] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*